期刊文献+

基质金属蛋白酶-25在萎缩性胃炎、胃癌组织中的表达及意义 被引量:1

Expression and significance of matrix metallproteinase-25 in gastric carcinoma
原文传递
导出
摘要 目的探讨基质金属蛋白酶-25(MMP-25)在胃癌中的表达及临床意义。方法采用免疫组织化学技术和逆转录一聚合酶链反应(RT—PCR)检测40例正常胃组织、40例萎缩性胃炎组织、40例胃癌组织中MMP-25的表达。结果免疫组织化学中,MMP-25在胃癌组织和萎缩性胃炎组织中的阳性率均明显高于正常胃组织(95.0%、82.5%、22.5%,P〈0.05);RT—PCR中,MMP-25在胃癌组织和萎缩性胃炎组织中的表达率均明显高于正常胃组织(0.328±0.005、0.175±0.002、0.103±0.004,P〈0.05)。MMP-25在癌组织中表达与肿瘤浆膜浸润、淋巴结转移及TNM分期明显相关(P〈0.05),与患者年龄、性别、肿瘤大小、分化程度等无明显相关(P〉0.05)。结论MMP-25在胃癌组织中高表达,与肿瘤的发生、转移有密切关系。 Objective To investigate the expression and clinical significance of matrix metallpro- teinase-25 (MMP-25) in gastric carcinoma. Methods The expression of MMP-25 in 40 cases of normal gastric tissue, 40 cases of atrophic gastritis and and 40 cases of gastric carcinoma was detected by using immunohistochemistry and reverse transcription-polymerase chain reaction (RT-PCR) separately. Results The expression rate of MMP-25 protein in gastric carcinoma and atrophic gastritis was significantly higher than in the normal gastric tissues (95.0% and 82. 5% vs. 22. 5%, P 〈 0. 05 ), and that of MMP-25 mRNA showed the same trend as the former (0. 328 ±0. 005 and 0. 175 ±0. 002 vs. 0. 103±0. 004,P 〈 0. 05 ). The expression of MMP-25 was significantly Correlated with the clinicopathologieal factors such as depth of invasion, lymph node metastasis and tumor sizes (P 〈 0. 05 ), but not with age, gender, clinical stage and differentiation (P 〉 0. 05 ). Conclusion The MMP-25 is expressed distinctly in gastric carcinoma. MMP-25 may be involved in tumorigenesis and metastasis of gastric carcinoma, and expected to be an important biomarker for gastric carcinoma, which could provide clues for clinical diagnosis of gastric carcinoma.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2012年第10期1997-1999,I0002,共4页 Chinese Journal of Experimental Surgery
关键词 基质金属蛋白酶-25 胃癌 转移 Matrix metallproteinase-25 Gastric carcinoma Metastasis
  • 相关文献

参考文献10

  • 1吴泽宇,李靖华,詹文华,何裕隆,彭俊生,蔡世荣.胃癌淋巴结微转移与基质金属蛋白酶-2表达的关系[J].中华实验外科杂志,2007,24(3):299-300. 被引量:17
  • 2English WR,Velasco G,Stracke J0,et al. Catalytic activities of mem-brane-type 6 matrix metalloproteinase ( MMP25). FEBS Lett,2001,491:137-142.
  • 3Sohail A, Sun Q, Zhao H,et al. MT4-(MMP17) and MT6-MMP(MMP25), A unique set of membrane-anchored matrix raetalloprotei-nases : properties and expression in cancer. Cancer Metastasis Rev,2008(27:289-302.
  • 4蔡铭,翁鸢,王志强,朱扣军,游庆军.基质金属蛋白酶在早期肺癌中的表达[J].中华实验外科杂志,2010,27(5):612-613. 被引量:10
  • 5Kubben FJ,Sier CF,van Duijn W,et al. Matrix metalloproteinase-2 isa consistent prognostic factor in gastric cancer. Br J Cancer,2006,94 :1035-1040.
  • 6徐涛,李乐平,石玉龙,苗瑞政,盛红光.膜型基质金属蛋白酶-1在浸润性肝细胞癌组织的表达及其意义[J].中华实验外科杂志,2012,29(1):80-82. 被引量:4
  • 7Kitoh T, Yanani H, Saitoh Y, et al. Increased expression of matrixmetalloproteinaae-7 in invasive early gastric cancer. Gastroenterol,2004,39-434440.
  • 8Starr AE, Bellac CL,Dufour A, et al. Biochemical characterization andN-terminomics analysis of leukolysin, the membrane-type 6 matrixmetalloprotease ( MMP25 ) : chemokine and vimentin cleavages en-hance cell migration and macrophage phagocytic activities. J BiolChem ,3012,13; 13382-13395.
  • 9Brown GD,Nazarali AJ. Matrix metalloproteinase-25 has a functionalrole in mouse secondary palate development and is a downstream tar-get of TGF-P3. BMC Dev Biol,2010,1:93-94.
  • 10Sun Q, Weber CR, Sohail A,et al. MMP25 ( MT6-MMP) is highlyexpressed in human coloncancer, promotes tumor growth,and exhibitsunique biochemical properties. J Biol Chem, 2007, 282: 21998-22010.

二级参考文献22

  • 1肖春花,冯玉梅,李晓青,郝希山.基质金属蛋白酶-2和纤维粘连蛋白在乳腺癌细胞系的定量表达[J].中华实验外科杂志,2005,22(5):527-529. 被引量:7
  • 2蔡铭,谢宗涛,翁鸢,常庆,常建华.韧黏素-C的分解与早期肺癌的术后复发转移[J].中华肿瘤杂志,2007,29(7):518-521. 被引量:1
  • 3Roy R,Yang J,Moses MA.Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.J Clin Oncol,2009,27:5287-5297.
  • 4Davies B,Waxman J,Wasan H,et al.Levels of matrix metalloproteinase in bladder cancer correlate with tumor grade and invasion.Cancer Res,1993,53:5365-5369.
  • 5Muller D,Breathnach R,Engelmann A,et al.Fxpression of collagenaserelated metalloproteinase genes in human lung or head and neck tumors.Int J Cancer,1991,48:550-556.
  • 6Suzuki M,lizasa T,Fujisawa T,et al.Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non.small.Cell lung cancer.Invasion Me tastasis,98-99,18:134-141.
  • 7Sun HCH. Progress in treatment of HCC aider operation. Oncol Prog, 2005.3 : 30 -32.
  • 8Hassink RJ, Dowell JD, Brutel A, et al. Stem cell therapy for ischemic heart disease. Trends Mol Med ,2003,9:436-441.
  • 9Golubkov VS, Chekanov AV, Savinov AY, el al. Membrane type-I ma- trix- metalloprotcinasc confers aneuploidy and tumorigenicity on mam- mary epithelial cells. Cancer Res,2006,66 : 10460-10465.
  • 10Takino T, Watanabe Y, Matsui M, et al. Membrane-type 1 matrix met- alloproteinase modulates focal adhesion stability and cell migration. Exp Cell Res,2006,312:1381-1389.

共引文献27

同被引文献3

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部